Testing safety of an experimental injection for obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational injection (JMT206) in people with obesity. The goal is to see if the medicine is safe and tolerable when given multiple times; it may help with weight management in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your BMI should be 30 or higher, which is in the obesity range.
- Your weight should have been stable for the last 3 months (no more than a 5% change).
- You must not have diabetes or a history of low blood sugar episodes.
- You must not have a history of certain stomach or pancreas problems, such as pancreatitis or gallbladder disease in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
Hear when a new Valid MeSH Conditiongs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.